Coastal Infusion Administers Briumvi®
| J-Code | J2329 |
|---|---|
| Manufacturer | TG Therapeutics |
| First Approved | 12/28/2022 |
Coastal Infusion can administer your Briumvi prescription at any of our south Florida locations.
Briumvi (ublituximab-xiiy) is used to treat relapsing or primary progressive forms of multiple sclerosis (MS). It is used in patients with active disease, who have relapses and/or signs of active inflammation on scans.
The active substance in Briumvi, ublituximab, is a monoclonal antibody (a type of protein) that has been designed to recognize and attach to a specific target called CD20 on the surface of B cells (a type of white blood cell). By targeting B cells, ublituximab is thought to stop white blood cells from entering the brain and spinal cord tissue, thereby reducing inflammation and the resulting nerve damage.
What It Treats
Briumvi is used to treat multiple sclerosis.
Prescribed By
Briumvi is most often prescribed by Neurologists.
How it’s Administered
Briumvi is administered by intravenous infusion. Briumvi infusions take about an hour.
Frequency
Briumvi infusions are generally administered every 24 weeks after a starter dose that is split into two separate infusions, two weeks apart.
Related Drugs
Additional Resources
The information on this page is compiled from a variety of online sources. Coastal Infusion has made every effort to verify its accuracy, but patients are advised to discuss any planned or current treatments with their doctor. Report inaccuracies